Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 5,395 shares at $58.24 ($313K) on 2010-09-01, disclosed to the SEC on 2010-09-01.
Open-market sale of $313k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.62 | 1,795 | $103K | 33.0% |
| 2 | $58.24 | 3,600 | $210K | 67.0% |
| Total | $58.03 avg | 5,395 | $313K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |